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INTRODUCTION
Despite increased availability of potent antimicrobials and
effective vaccines, bacterial meningitis continues to be a sig-
nificant cause of childhood morbidity and mortality. Many
clinical and etiologic studies performed over the past decades
have demonstrated that different species of bacteria cause puru-
lent meningitis. In neonatal period, Streptococcus agalactiae
and Gram-negative bacilli cause most bacterial meningitis
(1, 2). Haemophilus influenzae, Neisseria meningitidis and Strep-
tococcus pneumoniae were the most common causative organ-
isms of bacterial meningitis worldwide in childhood (3, 4).
In Korea, there was a report representing the basic epidemi-
ologic data of bacterial meningitis in children during the pre-
vious ten years (1986-1995) (5). Thereafter, new vaccines
such as Haemophilus influenza type b (Hib) conjugate vaccine
and heptavalent pneumococcal conjugate vaccine have been
introduced and many changes of the epidemiologic profile
are expected in Korea. Particularly, Hib vaccine was proved
to have good immunogenicity in Korean infants (6). Although
decline of invasive Hib diseases including meningitis has been
reported in many countries after the routine immunization
of Hib vaccine (7, 8), there is little investigation about child-
hood bacterial meningitis in Korea. Some studies demon-
strated that the incidence of Hib meningitis had decreased
after the introduction of Hib vaccine (9, 10). However, as
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The Causative Organisms of Bacterial Meningitis in Korean Children
in 1996-2005
Bacterial meningitis remains a serious cause of morbidity and mortality in childhood,
despite the availability of effective vaccines against Haemophilus influenzae type b
(Hib) or Streptococcus pneumoniae. The purpose of this study was to analyze data
on bacterial meningitis cases in Korea from 1996 through 2005. The information of
all hospitalized bacteria-proven meningitis cases was obtained from 17 university
hospitals nationwide. A total of 402 cases were identified. Of these, 125 (29.9%)
cases were neonates. Streptococcus agalactiae was the most common bacteria
responsible for 99 (24.6%) of all cases regardless of age, followed by S. pneumo-
niae for 91 (22.6%) and H. influenzae for 67 (16.7%) patients. The common etiolo-
gy beyond the neonatal period was S. pneumoniae for 91 (33.0%) followed by H.
influenzae for 63 (22.8%) patients. The overall case fatality rate was 9.4%, which
was similar with that in 1986-1995. In conclusion, S. agalactiae, S. pneumoniae
and H. influenzae were important etiologic agents of bacterial meningitis in children
in the last 10 yrs. It is required to establish the preventive strategy of the three bac-
teria. The nationwide epidemiologic study should be continued to evaluate immu-
nization strategy and efficacy.
Key Words : Meningitis, Bacterial; Etiology; Epidemiology; Streptococcus pneumoniae; Haemophilus influen-
zae; Streptococcus agalactiae; Neisseria meningitidis
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hospitals in a specific region, they might be insufficient to
reflect the general pediatric population in Korea. 
This study provides the comprehensive data of bacterial
meningitis in Korean children through a multicenter retro-
spective study for the past decade. Also, it will provide invalu-
able data for comparison of clinical features of the disease in
1986-1995 with those in 1996-2005. 
MATERIALS AND METHODS
Data on the medical records of bacterial meningitis patients
aged ≤18 yr admitted to 17 university hospitals through-
out Korea from January 1996 through December 2005, were
reviewed retrospectively. Among the hospitals participated
in this study, six were located in Seoul, another six in cities
nearby Seoul, and each of five hospitals was located in Gang-
won-do (Wonju), Chungcheongnam-do (Cheonan), Jeollabuk-
do (Jeonju), Gwangju, and Busan, respective. All bacteria
isolated in the patients with meningitis were included. Staphy-
lococcus epidermidis cultured in patients with cerebrospinal shunts
were excluded from the analysis. In this study, the criteria for
a definite diagnosis of bacterial meningitis were as following:
1) positive cerebrospinal fluid (CSF) culture of bacterial patho-
gen; 2) positive blood culture of bacteria with clinical features
and CSF findings concordant with bacterial meningitis; and
3) CSF positive for organisms causing bacterial meningitis
by latex agglutinin test and with pleocytosis (≥10 cells/mL)
in patients with meningeal irritative signs. Medical records
were examined for the followings: age, gender, bacterial eti-
ology of meningitis, fatality and complications. Organisms
were identified according to standard procedures in each hos-
pital, but bacterial isolates were not subcultured or serotyped. 
RESULTS
During the ten years, 402 patients were hospitalized with
bacterial meningitis in 17 hospitals. Of these, 231 patients
(57.5%) were male, and 169 patients (42.0%) were female
with a male to female ratio of 1.37:1. The ages of infected
children ranged from 0 day to 18 yr with a mean and median
age of 25 months and 3 months, respectively. Most patients
(330 cases, 82.1%) were ≤2 yr of age and 125 (31.2%) cases
were neonates. 
S. agalactiae (99 cases, 24.6%) was the most frequent etiolog-
ic agent in Korea, followed by S. pneumoniae (91 cases, 22.6%)
and H. influenzae (67 cases, 16.7%). And Escherichia coli (21
cases, 5.2%) and N. meningitidis (18 cases, 4.5%) were impor-
tant pathogens of bacterial meningitis in Korean children.
The category ‘‘others’’ included coagulase negative Staphylo-
coccus (26 cases, 6.5%), Streptococcus (other than S. agalactiae)
(15 cases, 3.7%), Staphylococcus aureus (15 cases, 3.7%), Kleb-
siella pneumoniae (11 cases, 2.7%), Enterococcus sp. (10 cases,
2.5%), Enterobacter cloacae (5 cases, 1.2%), Salmonella sp. (4
cases, 1.0%), Acinetobacter sp. (4 cases, 1.0%), Listeria sp. (3
cases, 0.7%), Pseudomonas aeruginosa (3 cases, 0.7%), Mycobac-
terium tuberculosis, Proteus mirabilis, Flavobacterium indologans
and Gram-negative bacilli (Table 1).
In the first 3 months of life, S. agalactiae (89 of 187, 47.6%)
and E. coli (18 of 187, 9.6%) were common organisms caus-
ing bacterial meningitis. Among S. agalactiae meningitis, only
8 cases presented within 6 days after birth and the remain-
ing cases presented between 7 days and 5 months. The com-
mon etiology beyond the neonatal period and under 5 yr of
age was S. pneumoniae for 32.1% (68 of 212), followed by H.
influenzae for 27.8% (59 of 212). In patients between 5 and
18 yr, S. pneumoniae (23 of 64, 35.9%) and N. meningitidis (15
of 64, 23.4%) were the major etiologic organisms of bacte-
rial meningitis. 
Through the ten years, yearly frequency of bacterial menin-
gitis was similar, however the cases of meningitis caused by
H. influenzae have decreased during the period, especially since
2001 (Fig. 1). Among a total of 67 H. influenzae meningitis
cases, 51 (76.1%) occurred between 1996 and 2000, thus, the
number of cases decreased by a third between 2001 and 2005.
Overall mortality rate was 9.5%. The fatalities as etiolog-
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The category ‘‘others’’ included coagulase negative Staphylococcus (26 cases, 6.5%), Streptococcus (other than S. agalactiae) (15 cases, 3.7%),
Staphylococcus aureus (15 cases, 3.7%), Klebsiella pneumoniae (11 cases, 2.7%), Enterococcus species (10 cases, 2.5%), Enterobacter cloacae (5
cases, 1.2%), Salmonella species (4 cases, 1.0%), Acinetobacter species (4 cases, 1.0%), Listeria species (3 cases, 0.7%), Pseudomonas aerugi-
nosa (3 cases, 0.7%), Mycobacterium tuberculosis, Proteus mirabilis, Flavobacterium indologans and gram-negative bacilli.
*Age not determined: 1.
Age of patient Total
No. (%) caused by
S. agalactiae E. coli H. influenzae S. pneumoniae N. meningitidis  Others
0 month 59 (47.2) 10 (8.0) 4 (3.2) 00000 2 (1.6) 50 (40.0) 125
1-2 month 30 (48.4) 8 (12.9) 7 (11.3) 3 (4.8) 0000 14 (22.6) 62
3-59 month 9 (6.0) 3 (2.0) 52 (34.7) 65 (43.3) 1 (0.7) 20 (13.3) 150
5-18 yr 00000 0000 4 (6.3) 23 (35.9) 15 (23.4) 22 (34.4) 64
Total 98* (24.4) 21 (5.2) 67 (16.7) 91 (22.7) 18 (4.5) 106 (26.4) 401*
Table 1. Age distribution of bacterial meningitis cases according to causative organisms, 1996-2005ic agents were 19.8%, 16.7% and 8.0% for S. pneumoniae, N.
meningitidis and S. agalactiae, respectively (Table 2). There was
no fatal case in meningitis patients caused by H. influenzae.
Various complications were developed in 20.1% of patients;
subdural effusion (7.5%), hydrocephalus (6.2%), hearing
impairment (5.5%), convulsion (3.5%), etc. The incidences
of complications according to etiologic agents were 27.3%,
26.9%, 23.8%, 20.9%, and 5.6% for S. agalactiae,H. influen-
zae,E. coli,S. pneumoniae and N. meningitidis, respectively.
DISCUSSION
This study provides the epidemiologic data about bacteri-
al meningitis in Korean children during the last decade. We
have shown the basic epidemiologic information of childhood
bacterial meningitis in a previous study. Therefore, these stud-
ies reflect the epidemiologic trend of bacterial meningitis in
Korean children for the last 20 yr. It cannot provide the inci-
dence of bacterial meningitis in the general population of
Korea, but can offer the relative frequency of causative organ-
isms by a multicenter study including hospitals distributed
throughout Korea. This investigation became more repre-
sentative of population characteristics because hospitals locat-
ed in more regions participated in it compared with the pre-
vious study.
From 1996 through 2005, the most common organism
of bacterial meningitis in Korean children was S. agalactiae,
followed by S. pneumoniae and H. influenzae. This result dif-
fers from the previous report that the leading causative organ-
ism of bacterial meningitis was S. pneumoniae (35.0%), fol-
lowed by H. influenzae (34.3%) and N. meningitidis (6.4%)
between 1986 and 1995 (5). However, the main reason of
this difference is due to the fact that the subjects of this study
included neonates. In many developed countries, S. agalacti-
ae caused most bacterial meningitis in the neonatal period
including premature and term babies up to 3 months of life
(11, 12). The incidence of neonatal S. agalactiae infection has
decreased since the implementation of intrapartum chemo-
prophylaxis in the United States and some European coun-
tries (13, 14). In the United States, Center for Disease Con-
trol and Prevention revised national guidelines in 2002, first
issued in 1996, which recommended universal late antenatal
screening of all pregnant women. However, the overall rates
of late-onset disease remained stable in spite of these guide-
lines, that is, it has only influenced the incidence of early-onset
S. agalactiae disease, not that of late-onset disease (1). In this
study 8.1% of S. agalactiae meningitis patients presented
within the first 6 days of life in contrast to the previous report
54.4% and 59.6% in the United States and European coun-
tries, respectively (1, 2). Considering the results of this study,
intrapartum antibiotic prophylaxis might not have a great
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Fig. 1. Yearly distribution of bacterial meningitis according to etiologic agents. The incidence of H. influenzae meningitis has markedly
decreased since 2001. 
*The category ‘‘others’’ included coagulase negative Staphylococcus (26 cases, 6.5%), Streptococcus (other than S. agalactiae) (15 cases,
3.7%), Staphylococcus aureus (15 cases, 3.7%), Klebsiella pneumoniae (11 cases, 2.7%), Enterococcus species (10 cases, 2.5%), Enter-
obacter cloacae (5 cases, 1.2%), Salmonella species (4 cases, 1.0%), Acinetobacter species (4 cases, 1.0%), Listeria species (3 cases,
0.7%), Pseudomonas aeruginosa (3 cases, 0.7%), Mycobacterium tuberculosis, Proteus mirabilis, Flavobacterium indologans and Gram-
negative bacilli.
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No. of death/No. of patients (%)
Table 2. Case fatality according to causative organisms
S. agalactiae 8/99 (8.0)
E. coli 1/21 (4.8)
H. influenzae 0/67 (0.0)
S. pneumoniae 18/91 (19.8)
N. meningitidis 3/18 (16.7)
Others 8/106 (7.5)
Total 38/402 (9.5) impact in the reduction of S. agalactiae disease in Korea. Other
preventive strategies of neonatal S. agalactiae infections such
as vaccination against this pathogen might be required. 
Beyond the neonatal period, S. pneumoniae and H. influen-
zae were major organisms causing bacterial meningitis dur-
ing the study period. H. influenzae has decreased as a major
pathogen of meningitis during ten years, especially since 2001
after Hib vaccine was introduced in Korea. Hib had been the
highest portion of etiologic agents of childhood bacterial
meningitis when Hib vaccine was not yet introduced (15).
In many countries, after Hib vaccine was introduced in nation-
al immunization programs invasive infections caused by Hib
reduced by more than 99% (3, 4, 16, 17). Replacement with
other capsular types has not occurred after the introduction
of Hib vaccines (18). In 2006, WHO recommended that Hib
vaccines be included in all routine infant immunization pro-
grams (19). Although H. influenzae isolates were not routinely
serotyped in this study, the reduced incidence of H. influen-
zae meningitis in Korea can be thought to be contributed
by effectiveness of Hib vaccine because more than 95% of
invasive diseases are caused by type b strain (3). Thus, with
the universal administration of Hib vaccine, further reduc-
tion of the incidence of bacterial meningitis caused by H.
influenzae may be expected in Korea.
S. pneumoniae is the most common etiology of childhood
bacterial meningitis in the United States and Africa region,
especially where Hib disease has been eliminated by vaccina-
tion (20-22). It is the second most frequently reported cause
of septic meningitis in European and sub-Saharan African
countries following meningococcal cases (23-25). Heptava-
lent pneumococcal conjugate vaccine (PCV7) covers against
seven of the most common and resistant strains (4, 6B, 9V, 14,
18C, 19F, and 23F) of S. pneumoniae. The incidence of pneu-
mococcal meningitis declined by 30.1%, especially nearly
60% in children younger than 5 yr of age after the introduc-
tion of conjugate vaccine against in the United States (26).
However, despite the introduction of PCV7, S. pneumoniae
remains the most common cause of childhood bacterial menin-
gitis in the United States (20). The reason of this has been
attributed to the replacement for pneumococcal meningitis
is observed for non-vaccine serotypes after widespread use of
PCV7, unlike H. influenzae (26). In addition, the circulating
serotypes can vary with geographical areas and relatively high
proportion of serotype 19A has been found among prevalent
serotypes of Korea (27). Thus, 10-valent (including serotype
1, 5 and 7V) and 13-valent vaccine (including serotype 1, 3,
5, 6A, 7F, and 19A) were developed. In this study, S. pneumo-
niae was the most common etiology beyond the neonatal peri-
od and under 5 yr as well as in patients between 5 and 18 yr.
PCV7 was introduced in 2003 in Korea. Because of insuffi-
cient vaccination coverage and slow implementation, decline in
the number of cases of pneumococcal meningitis was not ob-
served in this study. Further studies assessing the incidence of
pneumococcal meningitis in post-vaccination period are needed.
N. meningitidis was the third common agent for last two
decades in Korean children beyond the neonatal period, with
relatively low incidence compared with the United States and
European, African and Middle Eastern Asian countries (4, 12,
23-25, 28). The relative frequency of meningococcal menin-
gitis has increased after the introduction of the Hib vaccine
in the United States (21). Although meningococcus has con-
tributed relatively less to bacterial meningitis in Korean chil-
dren, watching changing incidence is important. 
The mortality rate for bacterial meningitis in children re-
ported in various countries ranged from 4% to 10% in more
recent studies (4). Case-fatality rate in this study was great-
est in pneumococcal meningitis similar to that shown in other
studies (4, 21, 29). Death by H. influenzae meningitis was
not found in our data. Reasons for this are that H. influenzae
meningitis can be well recovered when early treatment, includ-
ing the choice of adequate antibiotics, was started. Early use
of dexamethasone can help to decrease inflammation of men-
inges and prevent fatal outcome. Transient and permanent
complications were observed in 20% of patients in this report.
This rate was comparable to other reports where 20-50% of
survivors had serious and permanent sequelae such as epilep-
sy, mental retardation, deafness, learning impairment, sen-
sory-motor deficit and cerebral palsy (29, 30). 
Although our study demonstrated the trends and outcomes
of bacterial meningitis in Korean children, some limitations
of the study should be considered. This study included only
the patients who were admitted to university hospitals and
had lumbar punctures. And, antibiotic uses prior to hospital-
izations could make it difficult to detect organisms by culture,
especially before 2000 when antibiotics could be obtained
without a doctor’s prescription in Korea. These might result
in underestimation of the number of bacterial meningitis
cases. Another limitation is that we could not know the long-
term sequelae of the patients because the final outcomes of
the patients were determined at discharge or death. 
In conclusion, in the last 10 yrs S. agalactiae and E. coli were
the major etiologic agents of bacterial meningitis in neonates
and infants below 3 months, and S. pneumoniae, H. influenzae
and N. meningitidis in Korean children beyond 3 months.
Establishment of a preventive strategy for S. agalactiae infec-
tion in neonates is required. The universal administration of
Hib and pneumococcal conjugate vaccine should be adapt-
ed to the national immunization program. The nationwide
epidemiologic surveillance should be continued to give invalu-
able information which will have a great influence in mak-
ing important decisions on the national vaccination policy
and to evaluate the efficacy of newly adapted vaccines. 
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